Literature DB >> 14767473

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection.

Toru Nakamura1, Yoichi Furukawa, Hidewaki Nakagawa, Tatsuhiko Tsunoda, Hiroaki Ohigashi, Kohei Murata, Osamu Ishikawa, Kazuhisa Ohgaki, Nobuichi Kashimura, Masaki Miyamoto, Satoshi Hirano, Satoshi Kondo, Hiroyuki Katoh, Yusuke Nakamura, Toyomasa Katagiri.   

Abstract

To characterize molecular mechanism involved in pancreatic carcinogenesis, we analysed gene-expression profiles of 18 pancreatic tumors using a cDNA microarray representing 23,040 genes. As pancreatic ductal adenocarcinomas usually contain a low proportion of cancer cells in the tumor mass, we prepared 95% pure populations of pancreatic cancer cells by means of laser microbeam microdissection, and compared their expression profiles to those of similarly purified, normal pancreatic ductal cells. We identified 260 genes that were commonly upregulated and 346 genes that were downregulated in pancreatic cancer cells. Because of the high degree of purity in the cell populations, a large proportion of genes that we detected as upregulated or downregulated in pancreatic cancers were different from those reported in previous studies. Comparison of clinicopathological parameters with the expression profiles indicated that altered expression of 76 genes was associated with lymph-node metastasis and that of 168 genes with liver metastasis. In addition, expression levels of 30 genes were related to the recurrence of disease. These genome-wide expression profiles should provide useful information for finding candidate genes whose products might serve as specific tumor markers and/or as molecular targets for treatment of patients with pancreatic cancer.

Entities:  

Mesh:

Year:  2004        PMID: 14767473     DOI: 10.1038/sj.onc.1207392

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  81 in total

1.  FoxM1 mediates resistance to herceptin and paclitaxel.

Authors:  Janai R Carr; Hyun Jung Park; Zebin Wang; Megan M Kiefer; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 2.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

3.  Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer.

Authors:  Sally E Dowen; Tatjana Crnogorac-Jurcevic; Rathi Gangeswaran; Mikkel Hansen; Jyrki J Eloranta; Vipul Bhakta; Teresa A Brentnall; Jutta Lüttges; Gunther Klöppel; Nick R Lemoine
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

4.  Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection.

Authors:  Ming-Shiang Wu; Yi-Shing Lin; Yu-Ting Chang; Chia-Tung Shun; Ming-Tsan Lin; Jaw-Town Lin
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

5.  Breast cancer patient stratification using a molecular regularized consensus clustering method.

Authors:  Chao Wang; Raghu Machiraju; Kun Huang
Journal:  Methods       Date:  2014-03-18       Impact factor: 3.608

6.  Linkage analysis and gene expression profile of pancreatic acinar atrophy in the German Shepherd Dog.

Authors:  Leigh Anne Clark; Jacquelyn M Wahl; Jörg M Steiner; Wenli Zhou; Wan Ji; Thomas R Famula; David A Williams; Keith E Murphy
Journal:  Mamm Genome       Date:  2005-12-08       Impact factor: 2.957

7.  Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.

Authors:  Hyun-Soo Cho; John D Kelly; Shinya Hayami; Gouji Toyokawa; Masahi Takawa; Masanori Yoshimatsu; Tatsuhiko Tsunoda; Helen I Field; David E Neal; Bruce Aj Ponder; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

8.  Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).

Authors:  Brittany L Carpenter; Min Chen; Teresa Knifley; Kelley A Davis; Susan M W Harrison; Rachel L Stewart; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

9.  ZWINT is the next potential target for lung cancer therapy.

Authors:  Fang Peng; Qiang Li; Shao-Qing Niu; Guo-Ping Shen; Ying Luo; Ming Chen; Yong Bao
Journal:  J Cancer Res Clin Oncol       Date:  2019-01-14       Impact factor: 4.553

10.  Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.

Authors:  Reiko Takayama; Hidewaki Nakagawa; Akira Sawaki; Nobumasa Mizuno; Hiroki Kawai; Masahiro Tajika; Yasushi Yatabe; Keitaro Matsuo; Rie Uehara; Ken-ichiro Ono; Yusuke Nakamura; Kenji Yamao
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.